Beranda › Penyakit Sel Sabit › New York › New York City
Uji klinis Penyakit Sel Sabit di New York City, NY
13 studi untuk Penyakit Sel Sabit mencari peserta di lokasi sekitar New York City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
Menerima pesertaFase 1
- Mount Sinai Hospital, New York
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
Menerima pesertaFase 3
- Columbia University Medical Center_New York_0, New York
- Columbia University Medical Center_New York_0, New York
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
Menerima pesertaFase 2/3
- Icahn School of Medicine at Mount Sinai, New York
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Menerima pesertaStudi observasional
- Weill Cornell Medical College - New York Presbyterian Hospital, New York
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
Menerima pesertaFase 2
- Mount Sinai Medical Center, New York
Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease
Menerima pesertaFase 1/2
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering, New York
131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)
Menerima pesertaFase 1
- Columbia University Irving Medical Center, New York
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
Menerima pesertaStudi observasional
- Columbia Presbytarian (NT-DMT), New York
Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
Menerima pesertaFase 3
- New York Presbyterian Hospital - Morgan Stanley Children's Hospital, New York
Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
Menerima pesertaFase 2
- Columbia University, New York
A Long-term Follow-up Study in Patients Who Received BEAM-101
Menerima pesertaStudi observasional
- Columbia University Irving Medical Center, New York
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
Menerima peserta
- Weil Cornell Medical College, New York
Cannabinoids for the Reduction of Inflammation and Sickle Cell Related Pain
Menerima pesertaFase 2
- Mount Sinai Hospital, New York
Uji klinis Penyakit Sel Sabit di kota lain
- Atlanta, GA22 studi
- Washington, DC20 studi
- Chicago, IL18 studi
- Memphis, TN18 studi
- Philadelphia, PA15 studi
- Birmingham, AL14 studi
- St. Louis, MO12 studi
- Boston, MA10 studi
- Durham, NC10 studi
- Houston, TX10 studi
- Cincinnati, OH10 studi
- Greenville, NC9 studi
Studi lain di New York City
- Kanker Payudara136 studi
- Kanker Paru Non-Sel Kecil121 studi
- Kanker (semua jenis)109 studi
- Kanker Prostat103 studi
- Kanker Metastatik93 studi
- Kanker Kolorektal78 studi
- Kanker Ovarium69 studi
- Kanker Paru60 studi
- Mieloma Multipel60 studi
- Kanker Pankreas60 studi
- Kanker Endometrium52 studi
- Leukemia Mieloid Akut51 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.